Published in Epidemiol Psychiatr Sci on September 07, 2015
Major depression in multiple sclerosis: a population-based perspective. Neurology (2003) 2.09
How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med (2003) 1.54
Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (2005) 1.41
Poverty and mental illness. Can J Psychiatry (1997) 1.29
Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev (2007) 1.13
Mortality and cause of death among psychiatric patients: a 20-year case-register study in an area with a community-based system of care. Psychol Med (2009) 1.08
Amitriptyline for depression. Cochrane Database Syst Rev (2007) 1.07
Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data. Pharmacopsychiatry (2005) 1.07
Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. Acta Psychiatr Scand (2007) 0.94
Determinants of subjective quality of life in patients attending community-based mental health services. The South-Verona Outcome Project 5. Acta Psychiatr Scand (2002) 0.93
Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev (2003) 0.91
Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trials. Eur Psychiatry (1996) 0.89
Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. Int J Clin Pract (2013) 0.86
What is a multiple treatments meta-analysis? Epidemiol Psychiatr Sci (2012) 0.86
Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev (2003) 0.85
Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. J Psychopharmacol (2008) 0.85
Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. Br J Psychiatry (2007) 0.84
Mental disorders and conditions specifically related to stress. Epidemiol Psychiatr Sci (2013) 0.83
Cluster randomised trials. Epidemiol Psychiatr Sci (2011) 0.82
Clinical and regulatory implications of active run-in phases in long-term studies for bipolar disorder. Acta Psychiatr Scand (2013) 0.82
Implementing a data sharing culture. Epidemiol Psychiatr Sci (2016) 0.81
[The use of psychotropic drugs in an Italian psychiatric hospital: a two-year-long follow-up study]. Epidemiol Psichiatr Soc (2000) 0.81
Clozapine-treated subjects with treatment-resistant schizophrenia: a systematic review of experimental and observational studies. Int Clin Psychopharmacol (2002) 0.81
Guideline implementation in mental health: current status and future goals. Epidemiol Psychiatr Sci (2012) 0.81
What is the European Medicines Agency? Epidemiol Psychiatr Sci (2012) 0.81
Direct costs of schizophrenia in Italian community psychiatric services. Pharmacoeconomics (2001) 0.80
What is the WHO essential medicines list? Epidemiol Psychiatr Sci (2012) 0.80
Antidepressant drug prescribing in Italy, 2000: analysis of a general practice database. Eur J Clin Pharmacol (2001) 0.78
Dichotomizing rating scale scores in psychiatry: a bad idea? Epidemiol Psychiatr Sci (2012) 0.77
Epidemiology of first- and second-generation antipsychotic agents in Lombardy, Italy. Pharmacopsychiatry (2005) 0.76
Olanzapine on trial. Am J Psychiatry (1998) 0.75
Why it is important to include unpublished data in systematic reviews. Epidemiol Psychiatr Sci (2011) 0.75
Tryptophan and depression. Lancet (1997) 0.75
Low-dose neuroleptic therapy and extrapyramidal side effects in schizophrenia: An effect size analysis. Eur Psychiatry (1996) 0.75
Review: atypical antipsychotics are effective adjuncts for treatment resistant depression but increase discontinuation due to adverse effects. Evid Based Ment Health (2008) 0.75
Global mental health: achievements, concerns and (unanswered) questions. Epidemiol Psychiatr Sci (2016) 0.75
What is a factorial trial? Epidemiol Psychiatr Sci (2013) 0.75
Social and environmental adversities, neurobiological processes and mental disorders. Epidemiol Psychiatr Sci (2016) 0.75
Regulatory issues in Europe. J Clin Psychopharmacol (2001) 0.75
Studies of privileged sites and organ transplantation. Exp Nephrol (1994) 0.75
Antidepressant agents: from tricyclics to serotonin uptake inhibitors. Psychol Med (1998) 0.75
What is a Cochrane review? Epidemiol Psychiatr Sci (2011) 0.75
Colchicine allows prolonged survival of highly reactive renal allograft in the rat. J Am Soc Nephrol (1993) 0.75
Evidence-based medicine and medicine-based evidence. Neurol Sci (2005) 0.75
Improving access to medicines for mental disorders in low-resource settings: some achievements but still a long road ahead. Epidemiol Psychiatr Sci (2015) 0.75
Italy's mad law. Acta Psychiatr Scand (2000) 0.75
The Qualyop Project. 1: Monitoring the dismantlement of Italian public psychiatric hospitals. Characteristics of patients scheduled for discharge. Int J Soc Psychiatry (1999) 0.75
Evidence, knowledge, implementation: glossary of terminology. Epidemiol Psychiatr Sci (2017) 0.75
Corrections. Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis. Lancet Psychiatry (2015) 0.75
Clozapine and blood dyscrasias different from agranulocytosis. Can J Psychiatry (1997) 0.75